106 related articles for article (PubMed ID: 22768656)
21. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
Sasi W; Jiang WG; Sharma A; Mokbel K
BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
[TBL] [Abstract][Full Text] [Related]
22. Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.
Ugarte F; Irarrazabal C; Oh J; Dettmar A; Ceballos ML; Rojo A; Ibacache MJ; Suazo C; Lozano M; Delgado I; Cavada G; Azocar M; Delucchi A; Cano F
Pediatr Nephrol; 2016 Jun; 31(6):965-74. PubMed ID: 26747624
[TBL] [Abstract][Full Text] [Related]
23. [Expressions of SOCS in chondrocytes of patients with osteoarthritis].
Sun X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):186-9. PubMed ID: 23388339
[TBL] [Abstract][Full Text] [Related]
24. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction.
Favre H; Benhamou A; Finidori J; Kelly PA; Edery M
FEBS Lett; 1999 Jun; 453(1-2):63-6. PubMed ID: 10403376
[TBL] [Abstract][Full Text] [Related]
25. GH signaling in human adipose and muscle tissue during 'feast and famine': amplification of exercise stimulation following fasting compared to glucose administration.
Vendelbo MH; Christensen B; Grønbæk SB; Høgild M; Madsen M; Pedersen SB; Jørgensen JO; Jessen N; Møller N
Eur J Endocrinol; 2015 Sep; 173(3):283-90. PubMed ID: 26034073
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
27. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract][Full Text] [Related]
28. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
Zhang MY; Fung TK; Chen FY; Chim CS
J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
[TBL] [Abstract][Full Text] [Related]
29. Association between suppressors of cytokine signalling, T-helper type 1/T-helper type 2 balance and allergic sensitization in children.
Daegelmann C; Herberth G; Röder S; Herbarth O; Giese T; Krämer U; Behrendt H; Borte M; Heinrich J; Emmrich F; Lehmann I;
Clin Exp Allergy; 2008 Mar; 38(3):438-48. PubMed ID: 18167120
[TBL] [Abstract][Full Text] [Related]
30. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1.
Zhuang D; Qiu Y; Haque SJ; Dong F
J Leukoc Biol; 2005 Oct; 78(4):1008-15. PubMed ID: 16033816
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme.
Zhou H; Miki R; Eeva M; Fike FM; Seligson D; Yang L; Yoshimura A; Teitell MA; Jamieson CA; Cacalano NA
Clin Cancer Res; 2007 Apr; 13(8):2344-53. PubMed ID: 17438093
[TBL] [Abstract][Full Text] [Related]
33. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
Demirel I; Säve S; Kruse R; Persson K
APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
35. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
Story DJ; Stephens JM
Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
[TBL] [Abstract][Full Text] [Related]
36. Identification of suppressors of cytokine signaling (SOCS) proteins in human gestational tissues: differential regulation is associated with the onset of labor.
Blumenstein M; Bowen-Shauver JM; Keelan JA; Mitchell MD
J Clin Endocrinol Metab; 2002 Mar; 87(3):1094-7. PubMed ID: 11889171
[TBL] [Abstract][Full Text] [Related]
37. Differential roles of SOCS family members in EpoR signal transduction.
Jegalian AG; Wu H
J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
[TBL] [Abstract][Full Text] [Related]
38. Type II SOCS as a feedback repressor for GH-induced Igf1 expression in carp hepatocytes.
Jiang X; Xiao J; He M; Ma A; Wong AO
J Endocrinol; 2016 May; 229(2):171-86. PubMed ID: 27271287
[TBL] [Abstract][Full Text] [Related]
39. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
40. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
